Following a series of real time biomedical studies and aerobiological research by airmid‘s world leading environmental specialists, the flooring giant Tarkett has achieved a coveted health related certification. Tarkett FiberFloor is now certified by the Asthma and Allergy Foundation of America (AAFA) for both loose-lay (no glue) and adhered (glue-down) applications.
Much of the research centred around allergen removal validation studies in indoor climate controlled environmental test chambers.
During the floor certification process, the products were subjected to both physical and chemical tests to ensure they do not have properties that are likely to irritate both asthma and allergy symptoms in susceptible people – including low capacity for allergen retention, and low VOCs off gassing.
It is estimated that Americans spends over 90% of their time indoors and according to the EPA, the level of exposure to chemicals indoors can be five times greater than outdoors. Poor Indoor Air Quality (IAQ) is considered a leading factor for asthma and allergies symptoms.
Over 60 million people in the United States, nearly one out of five Americans, are affected by asthma and allergies. The number has doubled in the past 30 years and continues to grow.
Related tests
Floor Coverings
Environmental Test Chambers